comparemela.com

Carlsbad-based Tyra Biosciences ,a company developing precision medicines for targeting Fibroblast Growth Factor Receptor (FGFR) biology, has raised $200M in a private placement (PIPE). The publicly listed compan

Related Keywords

Tyra Biosciences ,Todd Harris ,Nextech Invest Ltd ,Bioscienes Scores ,Fibroblast Growth Factor Receptor ,Boxer Capital , ,

© 2025 Vimarsana

comparemela.com © 2020. All Rights Reserved.